Loading organizations...
§ Private Profile · Seattle, WA, USA
E-commerce platform modernizing healthcare distribution, enabling healthcare professionals to procure medical supplies directly from manufacturers.
Bttn has raised $27.0M across 3 funding rounds.
Key people at Bttn.
Bttn has raised $27.0M in total across 3 funding rounds.
Based in Seattle, Washington, Bttn operates a B2B e-commerce platform that modernizes healthcare distribution by connecting medical professionals directly with supply manufacturers and eliminating traditional middlemen. The company provides access to an inventory of over 2.5 million medical supplies through eight distribution centers, reducing procurement costs and fulfillment times for various healthcare facilities. As of mid-2022, the enterprise scaled its workforce to 75 employees and served more than 7,000 active clients across hospitals, dental clinics, and outpatient surgery centers. Bttn has secured $26.5 million in total venture funding, highlighted by a $20 million Series A financing round backed by institutional investors Tiger Global and FUSE that valued the business at $110 million. Guided by an executive leadership team that includes President Steve Nielsen, the organization was founded in 2021 by entrepreneurs JT Garwood and Jack Miller.
Bttn has raised $27.0M across 3 funding rounds. Most recently, it raised $20.0M Series A in June 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2022 | $20M Series A | Tiger Global | BAM Ventures, Ysplit, Sinai Ventures, Vine Ventures LP | Announced |
| Aug 1, 2021 | $5M Seed | Ysplit | BAM Ventures, Sinai Ventures, Vine Ventures LP, Aaron King, Flexcap, Kunal Shah, Oliver Jung, Robert Wuttke, Third Prime | Announced |
| Jun 1, 2021 | $2M Seed | — | Leawood Venture Capital | Announced |
Bttn has raised $27.0M in total across 3 funding rounds.
Bttn's investors include Tiger Global, Bam Ventures, Fuse, Sinai Ventures, Vine Ventures LP, Aaron King, Flexcap, Kunal Shah, Oliver Jung, Robert Wuttke, Third Prime, Leawood Venture Capital.
Key people at Bttn.
Bttn Technologies, Inc. (Bttn) is a privately-held B2B e-commerce marketplace and wholesale distributor specializing in medical supplies, lab equipment, and pharmaceuticals.[1][3] It serves healthcare professionals, businesses, and institutions by offering premium name-brand products with features like easy reordering from purchase history and prioritized support for account holders, solving inventory management challenges in the medical sector.[3] The company holds an A+ BBB rating and accreditation since 2022, with mixed customer feedback highlighting responsive service alongside concerns over stock availability.[2]
Bttn started operations on February 2, 2021, and was formally incorporated as a corporation on March 4, 2021, in Seattle, Washington.[2] Leadership includes CEO Richard Garwood and Principal JT Garwood, suggesting a family-led venture amid the pandemic-era surge in medical supply demand.[2] Early traction is reflected in its quick BBB accreditation by May 2022 and expansion to handle pharmaceuticals, requiring verified state licenses for buyers, which positioned it as a compliant distributor shortly after launch.[2][3]
Bttn rides the digitization wave in healthcare supply chains, where e-commerce platforms address inefficiencies in traditional medical distribution amid rising demand for lab equipment and pharmaceuticals post-pandemic.[1][3] Timing aligns with ongoing supply disruptions and regulatory needs for verified buyers, favoring agile tech-enabled wholesalers over legacy models.[2][3] It influences the ecosystem by lowering barriers for smaller practices via easy online access, though stock critiques highlight execution challenges in a competitive market.[2]
Bttn's compliant, user-friendly platform positions it for growth in the expanding medtech e-commerce space, potentially scaling through better inventory tech and broader product lines. Trends like AI-driven supply forecasting and telehealth integration could boost demand, evolving its role from pandemic responder to staple distributor—watch for funding or partnerships to solidify momentum amid mixed reviews. This ties back to its core as a vital link in medical supply accessibility.[1][2][3]
